Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 20/08/2026 BST
|
After hours 01:00:00 | |||
| 49.37 USD | -5.08% |
|
50.58 | +2.44% |
| 08-07 | Espiria Hållbar Framtid rose 2.5 percent in July - cut holdings in Bristol Myers Squibb, Merck and Novo Nordisk | FW |
| 08-05 | Wall Street warms to healthcare stocks as tech trade faces turbulence | RE |
| Market Cap | 71.55B 61.26B 57.16B 52.45B 98.55B 6,846B 100B 678B 264B 3,431B 269B 263B 11,359B | P/E 2026 * |
18.5x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 80.27B 68.72B 64.12B 58.84B 111B 7,680B 113B 761B 297B 3,849B 301B 295B 12,743B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.45x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +2.44% | ||
| 1 week | -4.49% | ||
| Current month | +5.65% | ||
| 1 month | +12.79% | ||
| 3 months | -12.88% | ||
| 6 months | -33.80% | ||
| Current year | -48.22% |
| 1 week | 49.36 |  | 52.56 |
| 1 month | 42.5 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% | ||
| 05/08/26 | Buy | Director | 2,100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.08% | -4.49% | -53.45% | -1.63% | 71.55B | |
| +2.28% | +5.31% | +26.83% | +17.88% | 232B | |
| +2.09% | +5.90% | +2.13% | -14.12% | 152B | |
| -5.84% | -6.68% | -22.06% | +30.96% | 132B | |
| -2.65% | -2.95% | +10.37% | +17.30% | 51.78B | |
| -0.43% | +1.97% | -17.34% | -12.52% | 51.75B | |
| +0.57% | +4.70% | +31.22% | +31.07% | 44.14B | |
| -2.68% | -2.13% | +36.38% | +49.89% | 39.76B | |
| -0.75% | +0.37% | +0.26% | +8.34% | 33.45B | |
| -0.67% | +0.75% | -20.97% | +37.89% | 32.95B | |
| Average | +0.06% | +0.49% | -0.66% | +16.50% | 84.15B | |
| Weighted average by Cap. | +0.94% | +1.36% | +1.89% | +13.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.29B 17.07B 15.66B 29.43B 2,044B 30.01B 202B 78.93B 1,025B 80.23B 78.48B 3,392B | 22.34B 19.12B 17.84B 16.37B 30.77B 2,137B 31.37B 212B 82.52B 1,071B 83.87B 82.05B 3,546B |
| Net income | 3.84B 3.29B 3.07B 2.82B 5.29B 368B 5.4B 36.42B 14.2B 184B 14.43B 14.12B 610B | 3.74B 3.2B 2.99B 2.74B 5.15B 358B 5.25B 35.43B 13.81B 179B 14.04B 13.73B 594B |
| Net Debt | 8.72B 7.46B 6.96B 6.39B 12.01B 834B 12.24B 82.61B 32.2B 418B 32.73B 32.02B 1,384B | 5.45B 4.67B 4.36B 4B 7.51B 522B 7.66B 51.67B 20.14B 261B 20.47B 20.02B 866B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | US$49.37 | -5.08% | 20,390,548 |
| 19/08/26 | US$52.01 | +3.05% | 16,834,155 |
| 18/08/26 | US$50.47 | -1.87% | 11,724,272 |
| 17/08/26 | US$51.43 | -0.77% | 18,151,325 |
| 14/08/26 | US$51.83 | +0.27% | 16,297,739 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
